Lantheus Holdings (LNTH) Return on Invested Capital (2015 - 2026)
Lantheus Holdings' (LNTH) quarterly Return on Invested Capital came in at 0.88% in Q1 2026, up 87.0% year-on-year from 0.47% in Q1 2025, and down 7.72% on a QoQ basis from 0.95% in Q4 2025.
Lantheus Holdings (LNTH) Return on Invested Capital (2015 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Return on Invested Capital data on file, last reported at 0.88% in Q1 2026.
- On a quarterly basis, Return on Invested Capital rose 87.0% year-over-year to 0.88% in Q1 2026; TTM through Mar 2026 was 0.88%, a 87.0% increase from a year earlier, with the FY2025 full-year figure at 3.65%, up 10105.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.88%, down from 0.95% in the prior quarter.
- Over the last five years, Return on Invested Capital for LNTH reached as high as 1.49% in Q1 2024 and fell as low as 0.15% in Q4 2024.
- Historically, Return on Invested Capital has averaged 0.27% across 5 years, with a median of 0.01% in 2025.
- Across the five-year window, Return on Invested Capital jumped 149 bps in 2024 and plunged 148 bps in 2025, its largest moves.
- Year by year, Return on Invested Capital stood at 0.0% in 2022, then surged by 1334 bps to 0.06% in 2023, then sank by 377 bps to 0.15% in 2024, then soared by 719 bps to 0.95% in 2025, then declined by 8 bps to 0.88% in 2026.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.88% in Q1 2026, 0.95% in Q4 2025, and 0.01% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 0.01% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 0.01% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 0.00% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 0.00% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 0.03% |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 0.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.88% |
| Dec 31, 2025 | 0.95% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | -0.15% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 1.22% |
| Mar 31, 2024 | 1.49% |
| Dec 31, 2023 | 0.06% |
| Sep 30, 2023 | 0.01% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.02% |
| Jun 30, 2022 | 0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |